Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/163382
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMajewski, Maciej-
dc.contributor.authorRuiz Carmona, Sergio-
dc.contributor.authorBarril Alonso, Xavier-
dc.date.accessioned2020-05-31T10:46:07Z-
dc.date.available2020-05-31T10:46:07Z-
dc.date.issued2019-09-17-
dc.identifier.issn2399-3669-
dc.identifier.urihttp://hdl.handle.net/2445/163382-
dc.description.abstractThe predominant view in structure-based drug design is that small-molecule ligands, once bound to their target structures, display a well-defined binding mode. However, structural stability (robustness) is not necessary for thermodynamic stability (binding affinity). In fact, it entails an entropic penalty that counters complex formation. Surprisingly, little is known about the causes, consequences and real degree of robustness of protein-ligand complexes. Since hydrogen bonds have been described as essential for structural stability, here we investigate 469 such interactions across two diverse structure sets, comprising of 79 drug-like and 27 fragment ligands, respectively. Completely constricted protein-ligand complexes are rare and may fulfill a functional role. Most complexes balance order and disorder by combining a single anchoring point with looser regions. 25% do not contain any robust hydrogen bond and may form loose structures. Structural stability analysis reveals a hidden layer of complexity in protein-ligand complexes that should be considered in ligand design.-
dc.format.extent8 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherSpringer Nature-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1038/s42004-019-0205-5-
dc.relation.ispartofCommunications Chemistry, 2019, vol. 2, p. 110-
dc.relation.urihttps://doi.org/10.1038/s42004-019-0205-5-
dc.rightscc-by (c) Majewski, Meciej et al., 2019-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es-
dc.sourceArticles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)-
dc.subject.classificationDisseny de medicaments-
dc.subject.classificationControl de robustesa-
dc.subject.classificationSíntesi proteica-
dc.subject.otherDrug design-
dc.subject.otherRobust control-
dc.subject.otherProtein synthesis-
dc.titleAn investigation of structural stability in protein-ligand complexes reveals the balance between order and disorder-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec695804-
dc.date.updated2020-05-31T10:46:07Z-
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/675899/EU//FRAGNET-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)

Files in This Item:
File Description SizeFormat 
695804.pdf1.33 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons